Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 1—January 2007

Research

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 1

Comparison of baseline characteristics of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003– 2004*

CharacteristicMDR Acinetobacter, 
n = 96Susceptible Acinetobacter, 
n = 91p values for MDR Acinetobacter vs. susceptible, n = 187Uninfected, 
n = 89p values for MDR Acinetobacter vs. uninfected, n = 185
Median age, y54520.61520.97
Age range, y14–8312–8517–90
Sex, % male67570.78650.96
Mean modified APACHE III score (median)41 (42)36 (33)0.0232 (28)<0.001
Mean Charlson index (median)3.9 (3.0)2.8 (2.0)0.012.5 (2.0)<0.01

*APACHE III, Acute Physiology and Chronic Health Evaluation III.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO